A detailed history of Country Trust Bank transactions in Moderna, Inc. stock. As of the latest transaction made, Country Trust Bank holds 318 shares of MRNA stock, worth $12,535. This represents 0.0% of its overall portfolio holdings.

Number of Shares
318
Previous 318 -0.0%
Holding current value
$12,535
Previous $21,000 38.1%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 08, 2024

SELL
$69.51 - $104.43 $17,377 - $26,107
-250 Reduced 44.01%
318 $31,000
Q4 2022

Jan 18, 2023

BUY
$118.38 - $210.04 $17,757 - $31,506
150 Added 35.89%
568 $0
Q4 2021

Jan 26, 2022

SELL
$225.82 - $368.51 $35,227 - $57,487
-156 Reduced 27.18%
418 $106,000
Q3 2021

Oct 26, 2021

SELL
$221.9 - $484.47 $164,871 - $359,961
-743 Reduced 56.42%
574 $221,000
Q4 2020

Feb 03, 2021

BUY
$65.74 - $169.86 $64,556 - $166,802
982 Added 293.13%
1,317 $138,000
Q1 2020

Apr 17, 2020

BUY
$17.78 - $31.58 $5,956 - $10,579
335 New
335 $10,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $15.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Country Trust Bank Portfolio

Follow Country Trust Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Country Trust Bank, based on Form 13F filings with the SEC.

News

Stay updated on Country Trust Bank with notifications on news.